Understand the source comparison
Thymalin vs Thymalin Khavinson Peptide: Research Application Comparison
Broad immune support studies Multi-peptide profile activates T-cell, B-cell, and NK-cell pathways simultaneously Targets thymic epithelial cells specifically. Limited effect on mature immune cells Glandular formulation preferred for whole-system immune modelin
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Broad immune support studies
- Multi-peptide profile activates T-cell, B-cell, and NK-cell pathways simultaneously
- Targets thymic epithelial cells specifically. Limited effect on mature immune cells
- Glandular formulation preferred for whole-system immune modeling
- Thymic involution reversal research
- Indirect thymic support through multiple pathways; mechanism less defined
- Direct action on thymic epithelial gene expression; measurable cortex regeneration in animal models
- Khavinson peptide preferred for mechanistic thymic regeneration studies
- Batch consistency requirements
- Variability in peptide composition (10–15% batch-to-batch fluctuation)
- >99% purity with exact sequence replication every batch
- Khavinson peptide required for reproducible dose-response studies
- Protein allergenicity risk
- Contains bovine proteins; potential immune response in sensitive models
- Synthetic dipeptide with minimal immunogenic potential
- Khavinson peptide preferred for prolonged dosing protocols
- Cost per research dose
- $40–60 per 10mg vial (wholesale research-grade)
- $25–35 per 20mg course (synthesized peptide)
- Khavinson peptide more cost-effective for extended trials
- Bottom Line
- Choose glandular Thymalin when modeling multi-pathway immune aging or replicating Soviet-era immune support protocols
- Choose Khavinson peptide when isolating thymic epithelial function, requiring batch consistency, or prioritizing mechanistic clarity over broad activity